HOME › DRUGS › CERITINIB
ACTIVE SUBSTANCE / INN

CERITINIB

Brand name(s): ZYKADIA, Zykadia
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
NDA211225
ACTIVE SUBSTANCE
Ceritinib
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS, Novartis Europharm Limited
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ZYKADIANDA205755NOVARTISDiscontinued
ZYKADIANDA211225NOVARTISPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZykadiaNovartis Europharm LimitedAuthorised06/05/2015Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON CERITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →